{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T12:59:48Z","timestamp":1648904388655},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1093\/humrep\/16.11.2434","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T10:14:16Z","timestamp":1485944056000},"page":"2434-2437","source":"Crossref","is-referenced-by-count":3,"title":["Are serum inhibin concentrations new markers of placental tumours in the course of chemotherapy?"],"prefix":"10.1093","volume":"16","author":[{"given":"P.","family":"Pautier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ghione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Brailly-Tabard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lhomm\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Morice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Bidart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,11]]},"reference":[{"key":"key\n\t\t\t\t20170215011725_AITKEN-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Aitken, D., Wallace, E.M., Crossley, J.A. et al. (1996) Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. N. Engl. J. Med., 334, 1231\u20131236.","DOI":"10.1056\/NEJM199605093341904"},{"key":"key\n\t\t\t\t20170215011725_AZAB-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Azab, M.B., Pejovic, M.H., Theodore, C. et al. (1988) Prognostic factors in gestational trophoblastic tumors. A multivariate analysis. Cancer, 62, 585\u2013592.","DOI":"10.1002\/1097-0142(19880801)62:3<585::AID-CNCR2820620324>3.0.CO;2-X"},{"key":"key\n\t\t\t\t20170215011725_BADONNEL-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Badonnel, Y., Barbe, F., Legagneur, H. et al. (1994) Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free beta-subunit. J. Clin. Endocrinol. Oxf., 41, 155\u2013162.","DOI":"10.1111\/j.1365-2265.1994.tb02524.x"},{"key":"key\n\t\t\t\t20170215011725_BAGSHAWE-1976","doi-asserted-by":"crossref","unstructured":"Bagshawe, K.D. (1976) Risk and prognostic factors in trophoblastic neoplasia. Cancer, 38, 1373\u20131385.","DOI":"10.1002\/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO;2-E"},{"key":"key\n\t\t\t\t20170215011725_BIDART-ETAL-1999","unstructured":"Bidart, J.M., Thuillier, F., Augereau, C. et al. (1999) Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring. Clin. Chem., 45, 1695\u20131707."},{"key":"key\n\t\t\t\t20170215011725_FAN-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Fan, C., Goto, S., Furuhashi, Y. et al. (1987) Radioimmunoassay of the serum free \u03b2-subunit of human chorionic gonadotropin in trophoblastic disease. J. Clin. Endocrinol. Metab., 64, 313\u2013318.","DOI":"10.1210\/jcem-64-2-313"},{"key":"key\n\t\t\t\t20170215011725_FLORIO-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Florio, P., Luisi, S., Casarosa, E. et al. (1998) Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy. J. Endocrinol. Invest., 21, 166\u2013169.","DOI":"10.1007\/BF03347296"},{"key":"key\n\t\t\t\t20170215011725_FOWLER-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Fowler, P.A., Evans, L.W., Groome, N.P. et al. (1998) A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy. Hum. Reprod., 13, 3530\u20133536.","DOI":"10.1093\/humrep\/13.12.3530"},{"key":"key\n\t\t\t\t20170215011725_FRIAS-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Frias, A.E., Li, H., Keeney, G.L. et al. (1999) Preoperative serum level of inhibin A is an independent prognostic factor for the survival of postmenopausal women with epithelial ovarian carcinoma. Cancer, 85, 465\u2013471.","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<465::AID-CNCR26>3.0.CO;2-W"},{"key":"key\n\t\t\t\t20170215011725_HEALY-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Healy, D.L., Burger, H.G., Mammers, P. et al. (1993) Elevated serum inhibin concentrations in post menopausal women with ovarian tumors. N. Engl. J. Med.,329, 1539\u20131542.","DOI":"10.1056\/NEJM199311183292104"},{"key":"key\n\t\t\t\t20170215011725_LAPPOHN-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Lapp\u00f6hn, R.E., Burger, H.G., Bouma, J. et al. (1989) Inhibin as a marker for granulosa-cell tumors. N. Engl. J. Med., 321, 790\u2013793.","DOI":"10.1056\/NEJM198909213211204"},{"key":"key\n\t\t\t\t20170215011725_MCCLUGGAGE-ETAL-1998","doi-asserted-by":"crossref","unstructured":"McCluggage, W.G., Ashe, P., McBride, H. et al. (1998) Localization of the cellular expression of inhibin in trophoblastic tissue. Histopathology, 32, 252\u2013256.","DOI":"10.1046\/j.1365-2559.1998.00385.x"},{"key":"key\n\t\t\t\t20170215011725_MINAMI-ETAL-1993","unstructured":"Minami, S., Yamoto, M. and Nakano, R. (1993) Immunohistochemical localisation of inhibin-activin subunits in hydatiform mole and invasive mole. Obstet. Gynecol., 82, 414\u2013418."},{"key":"key\n\t\t\t\t20170215011725_MUTTUKRISHNA-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Muttukrishna, S., Knight, P.G., Gromme, N.P. et al. (1997) Activin and inhibin A as possible endocrine markers for pre-eclampsia. Lancet, 349, 1285\u20131288.","DOI":"10.1016\/S0140-6736(96)09264-1"},{"key":"key\n\t\t\t\t20170215011725_OZTURK-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Ozturk, M., Bellet, D., Manil, L. et al. (1987) Physiological studies of human chorionic gonadotropin (hCG), \u03b1hCG, \u03b2hCG as measured by specific monoclonal immunoradiometric assays. Endocrinology, 120, 549\u2013558.","DOI":"10.1210\/endo-120-2-549"},{"key":"key\n\t\t\t\t20170215011725_PELKEY-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Pelkey, T.J., Frierson, H.F. Jr, Mills, S.E. et al. (1999) Detection of the alpha-subunit of inhibin in trophoblastic neoplasia. Hum. Pathol., 30, 26\u201331.","DOI":"10.1016\/S0046-8177(99)90296-4"},{"key":"key\n\t\t\t\t20170215011725_PETRAGLIA-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Petraglia, F., Garutti, G.C., Calza, L. et al. (1991) Inhibin subunits in human placenta: localisation and messenger ribonucleic acid levels during pregnancy. Am. J. Obstet. Gynecol., 164, 896\u2013900.","DOI":"10.1016\/0002-9378(91)90323-J"},{"key":"key\n\t\t\t\t20170215011725_PETRAGLIA-ETAL-1998","unstructured":"Petraglia, F., Florio, P., Luisi, S. et al. (1998) Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues.High levels of serum activin A in women with endometrial and cervical carcinoma. J. Clin. Endocrinol. Metab., 83, 1194\u20131200."},{"key":"key\n\t\t\t\t20170215011725_PETRAGLIA-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Petraglia, F., Zanin, E., Faletti, A. et al. (1999) Inhibins: paracrine and endocrine effects in female reproductive function. Curr. Opin. Obstet. Gynecol., 11, 241\u2013247.","DOI":"10.1097\/00001703-199906000-00002"},{"key":"key\n\t\t\t\t20170215011725_RILEY-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Riley, S.C., Wathen, N.C., Chard, T. et al. (1996) Inhibin in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum. Reprod., 11, 2772\u20132776.","DOI":"10.1093\/oxfordjournals.humrep.a019208"},{"key":"key\n\t\t\t\t20170215011725_RILEY-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Riley, S.C., Leask, R., Balfour, C. et al. (2000) Production of inhibin forms by the fetal membranes, decidua, placenta and fetus at parturition. Hum. Reprod., 15, 578\u2013583.","DOI":"10.1093\/humrep\/15.3.578"},{"key":"key\n\t\t\t\t20170215011725_ROBERTSON-ETAL-1996","unstructured":"Robertson, D., Burger, H.G., Sullivan, J. et al. (1996) Biological and immunological characterization of inhibin forms in human plasma. J. Clin. Endocrinol. Metab., 81, 669\u2013676."},{"key":"key\n\t\t\t\t20170215011725_SCHLAERTH-ETAL-1981","unstructured":"Schlaerth, J.B., Morrow, C.P., Kletsky, O.A. et al. (1981) Prognostic characteristics of serum human chorionic gonadotrophin titer regression following molar pregnancy. Obstet. Gynecol., 58, 478\u2013482."},{"key":"key\n\t\t\t\t20170215011725_SHIH-AND-KURMAN-1999","doi-asserted-by":"crossref","unstructured":"Shih, I.M. and Kurman, R.J. (1999) Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Int. J. Gynecol. Pathol., 18, 144\u2013150.","DOI":"10.1097\/00004347-199904000-00008"},{"key":"key\n\t\t\t\t20170215011725_WALLACE-AND-HEALY-1996","doi-asserted-by":"crossref","unstructured":"Wallace, E.M. and Healy, D.L. (1996) Inhibins and activins: role in clinical practice. Br. J. Obstet. Gynaecol., 103, 945\u2013956.","DOI":"10.1111\/j.1471-0528.1996.tb09541.x"},{"key":"key\n\t\t\t\t20170215011725_WALLACE-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Wallace, E.M., Riley, S.C., Crossley, J.A. et al. (1997) Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancy. J. Clin. Endocrinol. Metab., 82, 218\u2013222.","DOI":"10.1210\/jc.82.1.218"},{"key":"key\n\t\t\t\t20170215011725_WEBB-ETAL-1999","unstructured":"Webb, R., Campbell, B.K., Garverick, H.A. et al. (1999) Molecular mechanisms regulating follicular recruitment and selection. J. Reprod. Fertil., 54 (Suppl.), 33\u201348."},{"key":"key\n\t\t\t\t20170215011725_YEDEMA-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Yedema, K.A., Verheijen, R.H., Kenemans, P. et al. (1993) Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve. Am. J. Obstet. Gynecol., 168, 787\u2013792.","DOI":"10.1016\/S0002-9378(12)90820-0"},{"key":"key\n\t\t\t\t20170215011725_YOHKAICHIYA-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Yohkaichiya, T., Fukaya, T., Hoshiai, H. et al. (1989) Inhibin: a new circulating marker of hydatiform mole? Br. Med. J., 289, 1684\u20131686.","DOI":"10.1136\/bmj.298.6689.1684"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/16\/11\/2434\/9816987\/162434.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T04:42:22Z","timestamp":1503463342000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/681168\/Are"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2001,11]]},"published-print":{"date-parts":[[2001,11]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/16.11.2434","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}